8-K: BioAffinity Technologies Adjourns Special Stockholder Meeting

BioAffinity Technologies, Inc. adjourned its special stockholder meeting due to a lack of quorum, rescheduling it for January 19, 2026.

Summary

• BioAffinity Technologies, Inc. adjourned its special meeting of stockholders on December 19, 2025.
• The adjournment was due to an insufficient number of shares present in person or represented by proxy to constitute a quorum.
• The Special Meeting will reconvene on Monday, January 19, 2026, at 8:00 a.m. Central Time.
• The record date for determining eligible stockholders remains November 4, 2025.
• No changes have been made to the proposals to be voted on at the reconvened meeting.
• Stockholders who have previously submitted their proxy or otherwise voted and do not want to change their vote do not need to take any action.

Sentiment

Score: 4

Explanation: The adjournment of a special meeting due to a lack of quorum is a procedural setback, indicating a failure to achieve sufficient shareholder participation on the scheduled date. While the meeting is being reconvened, the initial inability to conduct business is a minor negative.

Negatives

• The company was unable to conduct its special meeting as scheduled due to a lack of quorum, indicating insufficient shareholder participation.

Risks

• Potential difficulty in obtaining sufficient shareholder participation for future votes.
• Delay in addressing the proposals intended for the special meeting.
• Possible perception of weak corporate governance or shareholder engagement.

Future Outlook

The special meeting is scheduled to reconvene on January 19, 2026, to address the original proposals without any changes.

Industry Context

Adjournments due to a lack of quorum can occur across industries, particularly for smaller companies or those with dispersed shareholder bases. This event highlights the importance of effective shareholder engagement and proxy solicitation efforts to ensure corporate actions can proceed as planned.

Corporate Governance

Stakeholder Impact

• Shareholders: Those who have not yet voted will have additional time to cast their votes. Those who have voted and do not wish to change their vote do not need to take further action. The delay means proposals will be addressed later than initially planned.

Next Steps

• The Special Meeting will reconvene on January 19, 2026, at 8:00 a.m. Central Time.
• Stockholders who have not yet voted or wish to change their vote can do so by following instructions in the definitive proxy statement.

Key Dates

Recommendation

The adjournment of a special meeting due to a lack of quorum is a procedural issue that could signal challenges in shareholder engagement or a lack of urgency among investors regarding the proposals. While not a fundamental business issue, it introduces a minor uncertainty and delay. Investors should hold and monitor the outcome of the reconvened meeting and the nature of the proposals to be voted on.

Keywords

bioAffinity Technologies, BIAF, special meeting, stockholder meeting, quorum, adjournment, corporate governance, SEC filing, 8-K, Nasdaq